Form 4: OPKO Health Director Acquires 60,000 Stock Options
SEC Form 4 Filing
Richard C. Pfenniger Jr., a director of OPKO Health, Inc., acquired 60,000 stock options on April 23, 2025.
Summary
- On April 23, 2025, Richard C. Pfenniger Jr., a director of OPKO Health, Inc., acquired 60,000 stock options.
- The exercise price of these options is $1.47.
- The options become exercisable on April 23, 2026, and expire on April 22, 2035.
- Following this transaction, Pfenniger directly owns 60,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction (stock option grant) for a director, suggesting standard compensation practices. It doesn't inherently indicate positive or negative performance expectations.
Positives
- A director's acquisition of stock options can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Insider transactions are closely monitored as they can provide insights into a company's prospects. Option grants are a common form of executive compensation in the healthcare industry.
Stakeholder Impact
- The acquisition of stock options by a director could potentially align the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/23/2025 | Date of transaction: Director acquired stock options. |
| 04/23/2026 | Date the stock options become exercisable. |
| 04/22/2035 | Expiration date of the stock options. |
Keywords
OPKO Health, Stock Options, Director, Acquisition, Form 4, Beneficial Ownership, Pfenniger, OPK
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.